Profile

Sanjay Kumar Gandhi, M.D.Wake Forest Baptist Health

Doctor Rating

4.5 out of 5

167 Ratings
16 Comments
 

Sanjay Kumar Gandhi, M.D.

Professor,

Clinical Interests

Pericardial Diseases, Structural Heart Disease, PFO/ASD Closure, Angioplasty, Cardiology (clinical), Cardiology (interventional)

Contact Information

Request An Appointment

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-6674
Department: 336-716-2095

Insurance Accepted »

Related Links

Education & Training

  • B.A., Emory University, 1988
  • M.D., Vanderbilt University School of Medicine, 1992
  • Residency, Internal Medicine, Vanderbilt Univ Medical Center, 1995
  • Fellowship, Vanderbilt Univ Medical School, 1996
  • Fellowship, Wake Forest University, 1999

Board Certifications

  • American Board of Internal Medicine, Cardiovascular Disease
  • American Board of Internal Medicine, Interventional Cardiology

NPI Number

  • 1295710275
Sanjay Kumar Gandhi, M.D.

Doctor Rating

4.5 out of 5

167 Ratings
16 Comments
 

Sanjay Kumar Gandhi, M.D.

Professor, Cardiology

Research Interests

Fluorobenzenes; Pyrimidines; Sulfonamides; Myocardial Infarction; Hydroxymethylglutaryl-CoA Reductase Inhibitors
More »

Contact Information

Request An Appointment

Academic: 336-716-2095 | Department: 336-716-2095

Related Links

Recent Publications

Transcatheter aortic valve replacement customization based on paravalvular aortic regurgitation location [abstract]. Gilbert ON, Hermann DD, Alvarez L, Deutsch C, Aldrich A, Sacrinty M, Pu M, Stacey R, Applegate R, Gandhi S, Zhao D.. J Am Coll Cardiol. 2015;65(10 Suppl):A1791.

Cardiac catheterization. Belford PM, Gandhi SK. In: Lefebvre C, O'Neill JC, Cline DM, eds. The atlas of cardiovascular emergencies. New York: McGraw-Hill Education;2015: 256-260.

Percutaneous closure of mitral paravalvular leak. Jones-Haywood MM, Combs C, Pu M, Gandhi SK, Dhawan R, Tempe DK.. J Cardiothorac Vasc Anesth. 2013;27(1):168-177.

Diagnostic time course, treatment, and in-hospital outcomes for patients with ST-segment elevation myocardial infarction presenting with nondiagnostic initial electrocardiogram: a report from the American Heart Association Mission: Lifeline program. Riley RF, Newby LK, Don CW, Roe MT, Holmes DN, Gandhi SK, Kutcher MA, Herrington DM.. Am Heart J. 2013;165(1):50-56.

Gender differences in vascular complications associated with transfemoral and transradial cardiac catheterization and PCI: a single-center experience [abstract]. Anderson J, Sacrinty M, Turner S, Gandhi S, Santos R, Kutcher M, Little W, Applegate R.. J Am Coll Cardiol. 2013;61(10 Suppl):E77.

Cost effectiveness of Everolimus-eluting compared to propensity score matched bare metal stenting: an analysis of a selected stent strategy [abstract]. Applegate RJ, Sacrinty M, Gandhi S, Kutcher M, Santos R, Little W.. J Am Coll Cardiol. 2013;61(10 Suppl):E1505.

Peak troponin I greater than 5 times the 99th percentile after PCI does not define a high-risk group [abstract]. Butler M, Sacrinty M, Little W, Applegate R, Kutcher M, Santos R, Gandhi S.. J Am Coll Cardiol. 2013;61(10 Suppl):E1879.

Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention. Applegate R, Sacrinty M, Schafer P, Smith J, Gandhi S, Kutcher M, Santos R, Cecile A, Little W.. Catheter Cardiovasc Interv. 2013;82(4):E375-E384.

Guidelines-based treatment of anaemic STEMI patients: practice patterns and effects on in-hospital mortality: a retrospective analysis from the NCDR. Riley RF, Newby LK, Don CW, Alexander KP, Peterson ED, Peng SA, Gandhi SK, Kutcher MA, Amsterdam EA, Herrington DM.. Europ Heart J Acute Cardiovasc Care. 2013;2(1):35-43.

Association between admission hemoglobin level and guideline-based therapy in patients with ST-segment elevation myocardial infarction: an analysis from the NCDR [abstract]. Riley RF, Newby LK, Don C, Gandhi S, Alexander K, Peng SA, Kutcher M, Amsterdam E, Herrington D.. J Am Coll Cardiol. 2012;59(13 Suppl):E1817.

Timing of electrocardiographic diagnosis in ST-segment elevation myocardial infarction patients with an initial non-diagnostic electrocardiogram: an observational analysis from the NCDR [abstract]. Riley RF, Newby LK, Don C, Roe M, Holmes DN, DaJuanicia N, Gandhi S, Kutcher M, Herrington D.. J Am Coll Cardiol. 2012;59(13 Suppl):E418.

Cost-effectiveness analysis of propensity matched radial and femoral cardiac catheterization and coronary intervention [abstract]. Schafer P, Sacrinty MT, Smith JW, Little W, Gandhi S, Kutcher M, Santos R, Smith T, Cecile AC, Applegate R.. J Am Coll Cardiol. 2012;59(13 Suppl):E72.

Transitioning to the radial artery as the preferred access site for cardiac catheterization: an academic medical center experience. Turner S, Sacrinty M, Manogue M, Little W, Gandhi S, Kutcher M, Santos R, Applegate R.. Catheter Cardiovasc Interv. 2012;80(2):247-257.

Contrast use and acute kidney injury in contemporary clinical practice [abstract]. Applegate R, Sacrinty M, Allem J, Gandhi S, Kutcher M, Santos R, Smith T, Little W.. J Am Coll Cardiol. 2012;60(17 Suppl B):B39-B40.

Cost effectiveness of Everolimus-eluting stents compared to first generation drug-eluting stents in contemporary clinical practice [abstract]. Applegate R, Sacrinty M, Gandhi S, Kutcher M, Santos R, Smith T, Little W.. J Am Coll Cardiol. 2012;60(17 Suppl B):B185.

Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice. Schafer PE, Sacrinty MT, Cohen DJ, Kutcher MA, Gandhi SK, Santos RM, Little WC, Applegate RJ.. Circ Cardiovasc Qual Outcomes. 2011;4(4):408-415.

Bleeding avoidance strategy: transition from femoral to radial artery as the preferred access for cardiac procedures. The Wake Forest academic medical center experience [abstract]. Manogue MR, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Turner SJ, Applegate RJ.. J Am Coll Cardiol. 2011;57(14 Suppl 1):E1057.

Cost effectiveness of drug-eluting stents versus bare metal stents in clinical practice: effect of stent length and diameter [abstract]. Schafer P, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, Applegate RJ.. J Am Coll Cardiol. 2011;57(14 Suppl 1):E1184.

Cath lab utilization during transition to the radial artery as preferred access: the Wake Forest academic medical center experience [abstract]. Turner S, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Manogue MR, Applegate RJ.. J Am Coll Cardiol. 2011;57(14 Suppl):E1269.

Prehospital administration of tenecteplase for ST-segment elevation myocardial infarction in a rural EMS system. Crowder JS, Hubble MW, Gandhi S, McGinnis H, Zelman S, Bozeman W, Winslow J.. Prehosp Emerg Care. 2011;15(4):499-505.

Resource utilization for propensity matched radial and femoral catheterization and intervention [abstract]. Schafer PE, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Cecile AC, Applegate RJ.. J Am Coll Cardiol. 2011;58(20 Suppl B):B146-B147.

Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes. Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.. J Invasive Cardiol. 2010;22(6):266-270.

Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC.. Circ Cardiovasc Interv. 2009;2(1):35-42.

3-year comparison of drug-eluting versus bare-metal stents. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC.. J Am Coll Cardiol Intv. 2009;2(3):231-239.

Three-year comparison of drug-eluting versus bare metal stents [abstract]. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC.. J Am Coll Cardiol. 2009;53(10 Suppl 1):A353.

Clinical outcomes of bare metal stents versus drug-eluting stents target vessel revascularization: evidence for a high-risk bare metal stent cohort [abstract]. Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.. J Am Coll Cardiol. 2009;53(10 Suppl 1):A317-A318.

Drug-eluting stent versus bare metal stent use in patients with chronic kidney disease [abstract]. Santos RM, Sacrinty MJ, Kutcher MA, Gandhi SK, Little WC, Applegate RJ.. J Am Coll Cardiol. 2009;53(10 Suppl 1):A393-A394.

Prognostic implications of vascular complications following PCI. Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R.. Catheter Cardiovasc Interv. 2009;74(1):64-73.

Acute heart failure with preserved systolic function. Kumar R, Gandhi SK, Little WC.. Crit Care Med. 2008;36(1 Suppl):S52-S56.

'Off-label' stent therapy: 2-year comparison of drug-eluting versus bare-metal stents. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC.. J Am Coll Cardiol. 2008;51(6):607-614.

Culprit vessel PCI versus traditional cath and PCI for STEMI. Applegate RJ, Graham SH, Gandhi SK, Kutcher MA, Sacrinty MT, Santos RM, Little WC.. J Invasive Cardiol. 2008;20(5):224-228.

Drug-eluting stents versus bare metal stents in saphenous vein grafts at 2 years [abstract]. Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.. J Am Coll Cardiol. 2008;51(10 Suppl B):B78.

Drug-eluting stents for ST elevation myocardial infarction: evidence for benefit at two years [abstract]. Gandhi SK, Kay JD, Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Little WC.. J Am Coll Cardiol. 2008;51(10 Suppl B):B1.

Culprit vessel primary percutaneous coronary intervention for ST elevation myocardial infarction shorter door to balloon time [abstract]. Graham SH, Applegate RJ, Gandhi SK, Sacrinty MT, Baki TT, Santos RM, Little WC, Kutcher MA.. J Am Coll Cardiol. 2008;51(10 Suppl B):B61.

Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes. Turner SJ, Ketch TR, Gandhi SK, Sane DC.. Am Heart J. 2008;155(5):806-816.

Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC.. J Am Coll Cardiol Intv. 2008;1(3):317-326.

Late outcomes of drug-eluting versus bare meta stents in saphenous vein grafts: propensity score analysis. Applegate RJ, Sacrinty M, Kutcher M, Santos R, Gandhi S, Little W.. Catheter Cardiovasc Interv. 2008;72(1):7-12.

Incidence of coronary stent thrombosis based on academic research consortium definitions. Applegate RJ, Sacrinty MT, Little WC, Santos RM, Gandhi SK, Kutcher MA.. Am J Cardiol. 2008;102(6):683-688.

Prognostic implications of post percutaneous coronary intervention vascular complications [abstract]. Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.. Am J Cardiol. 2008;102(8A Suppl):9i.

Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC.. Am J Cardiol. 2007;99(3):333-338.

Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaeous coronary intervention using thrombin hemostatic patch-facilitated manual compression. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Kahl FR, Little WC.. J Invasive Cardiol. 2007;19(4):164-170.

A protocol for the perioperative management of patients with intracoronary drug-eluting stents [newsletter article]. Newsome LT, Kutcher MA, Gandhi SK, Prielipp RC, Royster RL.. APSF [Anesthesia Patient Safety Foundation] Newsl. 2007;21(4):81-82.

Vascular complications following cardiac catheterization and coronary intervention 1998-2005: influence of gender [abstract]. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC.. J Am Coll Cardiol. 2007;49(9 Suppl):193A.

Vascular complications in women after catheterization and percutaneous coronary intervention 1998-2005. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Kahl FR, Santos RM, Little WC.. J Invasive Cardiol. 2007;19(9):369-374.

Vascular complications 1998-2007: evidence for better outcomes [abstract]. Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.. Am J Cardiol. 2007;100(8 Suppl 1):6L.

Off-label DES vs. BMS treatment: outcomes at 2 years [abstract]. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Baki TT, Gandhi SK, Little WC.. Am J Cardiol. 2007;100(8 Suppl 1):159L.

Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy. Call J, Sacrinty M, Applegate R, Little W, Santos R, Baki T, Gandhi S, Kahl F, Kutcher M.. J Invasive Cardiol. 2006;18(10):469-474.

Late outcomes after intervention of vein grafts in diabetics with abciximab use. Applegate RJ, Upadhya B, Little WC, Xenakis M, Gandhi SK, Baki TT, Kahl FR, Kutcher MA.. Int J Cardiol. 2006;111(1):136-141.

Vascular complications after cath and percutaneous coronary intervention: thrombin hemostatic patch versus manual compression [abstract]. Applegate RJ, Kutcher MA, Little WC, Sacrinty MT, Gandhi SK, Baki TT, Santos RM.. Circulation. 2006;114(18 Suppl):II-392.

PCI with and without abciximab after upstream eptifibatide use: outcomes in high-risk patients. Applegate RJ, Grabarczyk MA, Sane DC, Sacrinty MT, Goodin JE, Statonk GS, Baki TT, Gandhi SK, Kutcher MA, Little WC.. J Invasive Cardiol. 2006;18(12):604-613.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Cardiology

Clinical Interests

Pericardial Diseases, Structural Heart Disease, PFO/ASD Closure, Angioplasty, Cardiology (clinical), Cardiology (interventional)
Sanjay Kumar Gandhi, M.D.

Sanjay Kumar Gandhi, M.D.

Professor, Cardiology

Request An Appointment

Doctor Rating

4.5 out of 5

Sanjay Kumar Gandhi, M.D.167 Ratings
16 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.6
CP efforts to include in decisions
4.6
CP explanations of prob/condition
4.6
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.7
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.7
Time CP spent with patient
4.4
Wait time at clinic
3.7



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

5/27/2016

He the best.

5/3/2016

Felt better seeing provider knowing he would do everything possible to help me.

4/18/2016

Dr. Gahndi is an excellent physician.

4/16/2016

He is very busy.

3/28/2016

*Dr. Gandhi is the best!

3/7/2016

very very good

2/25/2016

Dr. was in a hurry. Didn't have time to answer all my questions. #1-7. In a hurry.

1/3/2016

The secret to my Awesome recovery, is Doctor Sanjay Gandhi who simply extraordinary. I wished he was around when my Mom had heart attack at 48 years old and died. I will be 70 years old 02/14/46.Dr. Sanjay Grandhi There is a reason he is Nationally Ranked Cardiologist.

12/22/2015

excellent care

12/1/2015

*Dr. Gandhi is knowledgeable, compassionate.

11/16/2015

I'm satisfied

11/10/2015

We recommend Dr. Gandhi to everyone needing a Cardiologist.

10/4/2015

Very good experience ,without problems

9/30/2015

I recommend Dr. Gandhi to everyone who is seeking a Cardiologist!

9/25/2015

No complaints.

9/21/2015

Again,Dr. Ghandi seems to be in a big hurry to get in and out of the room

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.